Harel Insurance Investments & Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-236	Closed	-$32K	–	558
2024 Q1	$32K	Hold	236	–	–	﹤0.01%	410
2023 Q4	$32K	Hold	236	–	–	﹤0.01%	470
2023 Q3	$29K	Hold	236	–	–	﹤0.01%	517
2023 Q2	$30K	Hold	236	–	–	﹤0.01%	535
2023 Q1	$30K	Hold	236	–	–	﹤0.01%	551
2022 Q4	$31K	Hold	236	–	–	﹤0.01%	539
2022 Q3	$27K	Hold	236	–	–	﹤0.01%	571
2022 Q2	$27K	Hold	236	–	–	﹤0.01%	607
2022 Q1	$30K	Sell	236 -244	-51%	-$31.8K	﹤0.01%	598
2021 Q4	$72K	Hold	480	–	–	﹤0.01%	539
2021 Q3	$77K	Hold	480	–	–	﹤0.01%	486
2021 Q2	$78K	Hold	480	–	–	﹤0.01%	672
2021 Q1	$72K	Hold	480	–	–	﹤0.01%	631
2020 Q4	$52K	Hold	480	–	–	﹤0.01%	600
2020 Q3	$65K	Hold	480	–	–	﹤0.01%	429
2020 Q2	$65K	Hold	480	–	–	﹤0.01%	375
2020 Q1	$51K	Hold	480	–	–	﹤0.01%	273
2019 Q4	$57K	Hold	480	–	–	﹤0.01%	347
2019 Q3	$47K	Hold	480	–	–	﹤0.01%	313
2019 Q2	$52K	Sell	480 -141,300	-100%	-$15M	﹤0.01%	302
2019 Q1	$15.9M	Hold	141,780	–	–	0.92%	31
2018 Q4	$13.7M	Buy	141,780 +1,725	+1%	+$183K	0.84%	37
2018 Q3	$17.1M	Sell	140,055 -172,925	-55%	-$20.4M	0.84%	38
2018 Q2	$34.4M	Sell	312,980 -505	-0.2%	-$54K	1.82%	15
2018 Q1	$33.5M	Hold	313,485	–	–	1.89%	17
2017 Q4	$33.5M	Sell	313,485 -81	-0%	-$8.66K	2.1%	11
2017 Q3	$34.9M	Sell	313,566 -420	-0.1%	-$44.9K	2.86%	7
2017 Q2	$32.5M	Buy	313,986 +136,320	+77%	+$13.4M	2.62%	8
2017 Q1	$17.4M	Buy	177,666 +4,227	+2%	+$405K	1.52%	21
2016 Q4	$16.7M	Hold	173,439	–	–	2.37%	10
2016 Q3	$16.7M	Sell	173,439 -6,741	-4%	-$641K	2.26%	11
2016 Q2	$15.5M	Buy	180,180 +7,380	+4%	+$662K	1.85%	14
2016 Q1	$15M	Hold	172,800	–	–	1.8%	18
2015 Q4	$19.5M	Buy	+172,800	New	+$18.8M	2.26%	15

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Harel Insurance Investments & Financial Services's IBB Position: Q2 2024 in Review

Harel Insurance Investments & Financial Services sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 236 shares — an estimated $32K sold.

Harel Insurance Investments & Financial Services first reported a position in IBB in Q4 2015 and held it in 34 quarters. The position peaked at $34.9M in Q3 2017. 895 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

Harel Insurance Investments & Financial Services reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 236 iShares Biotechnology ETF shares in Q2 2024, an estimated $32K.
Harel Insurance Investments & Financial Services first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 34 quarters.
Harel Insurance Investments & Financial Services's iShares Biotechnology ETF position peaked at $34.9M in Q3 2017.
895 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2024, filed 22 Jul 2024.